Most patients with pancreatic ductal adenocarcinoma (PDAC) present with symptomatic,
surgically unresectable disease. Although the goal of early detection of PDAC is laudable …

Computed tomography is the first-line imaging modality for suspected pancreatic cancer.
Magnetic resonance cholangiopancreatography is a second-line modality for suspected …

Pancreatic ductal adenocarcinoma is an aggressive malignancy with a high mortality rate.
Proper determination of the extent of disease on imaging studies at the time of staging is one …

Pancreatic ductal adenocarcinoma (PDAC) has continued to have a poor prognosis for the
last few decades in spite of recent advances in different imaging modalities mainly due to …

Pancreatic ductal adenocarcinoma (PDA) remains among the most challenging
malignancies to treat. At diagnosis, the tumor often already extends beyond the confines of …

Certain inflammatory pancreatic abnormalities may mimic pancreatic ductal
adenocarcinoma at imaging, which precludes accurate preoperative diagnosis and may …

Background Pancreatic cancer is a highly lethal cancer with no established a priori markers
of survival. Existing nomograms rely mainly on post-resection data and are of limited utility in …

Pancreatic ductal adenocarcinoma (PDAC), an epithelial neoplasm derived from the
pancreatic ductal tree, is the most common histologic type of pancreatic cancer and …

Pancreatic cancer is a highly lethal malignancy which is increasing in incidence and
mortality. The fourth leading cause of cancer death in the US, pancreatic cancer is projected …

AIM: To evaluate lesion contrast in pancreatic adenocarcinoma patients using spectral
multidetector computed tomography (MDCT) analysis. MATERIALS AND METHODS: The …